Trial Profile
Multimodal Post-Cesarean Analgesia With Spinal Morphine and Continuous Wound Infiltration of Ropivacaine Using the OnQ Elastomeric Pump: A Dose-Ranging Study Using a High-Volume, Low-Dose Protocol
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Oct 2020
Price :
$35
*
At a glance
- Drugs Ropivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 07 Oct 2019 Status changed from recruiting to completed.
- 01 Mar 2019 Planned number of patients changed from 60 to 70.
- 01 Mar 2019 Planned End Date changed from 1 Jul 2019 to 1 Dec 2019.